Article info
PDFOriginal Articles: Chemotherapy
Phase II Study of Pegylated Liposomal Doxorubicin and Carboplatin in Patients With Platinum-Sensitive and Partially Platinum-Sensitive Metastatic Ovarian Cancer
- Address correspondence and reprint requests to Bernardo L. Rapoport, MD, The Medical Oncology Centre of Rosebank, PO Box 2040, Parklands 2121, Johannesburg, South Africa. E-mail: brapoport{at}icon.co.za.
Citation
Phase II Study of Pegylated Liposomal Doxorubicin and Carboplatin in Patients With Platinum-Sensitive and Partially Platinum-Sensitive Metastatic Ovarian Cancer
Publication history
- Received September 5, 2008
- First published July 1, 2009.
Online issue publication
March 06, 2019
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright © 2009 by IGCS and ESGO